Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-1997 | 05-1997 | 02-1997 | 11-1996 | 08-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,579 | 7,671 | 44,040 | 32,710 | 16,746 |
| Depreciation Amortization | 4,656 | 2,089 | 6,272 | 4,895 | 3,125 |
| Other Working Capital | -34,211 | 6,280 | -9,797 | -14,113 | -16,846 |
| Other Operating Activity | 32 | 436 | -1,062 | 0 | 0 |
| Operating Cash Flow | $-6,944 | $16,476 | $39,453 | $23,492 | $3,025 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,954 | -5,141 | -17,654 | -12,424 | -9,560 |
| Net Acquisitions | 680 | 0 | 0 | 0 | 0 |
| Other Investing Activity | -34,750 | -25,100 | 4,283 | 4,800 | 0 |
| Investing Cash Flow | $-44,024 | $-30,241 | $-13,371 | $-7,624 | $-9,560 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -17,964 | -17,894 | -15,242 | 950 | 584 |
| Financing Cash Flow | $-17,964 | $-17,894 | $-15,242 | $950 | $584 |
| Beginning Cash Position | 71,887 | 71,887 | 61,047 | 61,047 | 61,047 |
| End Cash Position | 3,225 | 40,228 | 71,887 | 77,865 | 55,096 |
| Net Cash Flow | $-68,662 | $-31,659 | $10,840 | $16,817 | $-5,951 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,944 | 16,476 | 39,453 | 23,492 | 3,025 |
| Free Cash Flow | -6,944 | 16,476 | 39,453 | 23,492 | 3,025 |